Sep 2026· Ecotoxicology and Environmental Safety· Vol 324, pp.
120868
· 0 citations· 32 references
Medicine
TL;DR
Experimental evidence for the bone toxicity of BPS is provided and a scientific basis for understanding its potential role in osteoporosis is offered.
Abstract
Bisphenol S (BPS) is an environmental pollutant widely detected in nature. Given the high global burden of osteoporosis and increased human exposure to BPS, studying its potential bone toxicity is of great significance, but its underlying mechanisms are still unclear. Here, we explored the potential mechanism of BPS-induced osteoporosis by combining network toxicology, molecular docking, normal mode analysis (NMA), and in vitro experimental verification. By overlapping BPS-related genes with genes associated with osteoporosis, we identified 14 overlapping targets, which were mainly enriched in IL-17/TNF signaling pathways. Four hub targets (SIRT1, MMP2, MMP3, JAK2) were identified based on four topological algorithms, and all exhibited strong binding affinity and stable interactions in molecular docking and NMA study. In vitro experiments showed that, in the BPS exposure model, calcium deposition in ARS staining was reduced, alkaline phosphatase (ALP) activity was inhibited, and the mRNA expression of osteogenic markers decreased in MC3T3-E1 cells. In addition, qRT-PCR analysis confirmed significant downregulation of SIRT1, MMP2, MMP3, and JAK2. Collectively, these findings provide experimental evidence for the bone toxicity of BPS and offer a scientific basis for understanding its potential role in osteoporosis.
This study identifies the core targets and signaling pathways mediating BPA-induced MASLD, establishing an integrated computational framework for risk assessment of environmental hepatotoxicants and providing a theoretical basis for BPA regulatory policy formulation and MASLD mechanistic research.
Yue Li, Zhuo Xiong, Yun-Di Zhang et al.· Frontiers in Pharmacology· 0 citations
The findings suggest that BPS may exacerbate PCOS progression by upregulating EGFR, ESR1 and IGF1 to inhibit granulosa cell growth, and thereby disrupt ovarian oxidative homeostasis, hormone signaling, insulin metabolism and cell-cycle regulation via the PI3K-Akt and FoxO pathways.
Juan Liu, Guo-Lin Ye, Xin Liu et al.· International Journal of Mol...· 0 citations
Bisphenol A (BPA), a widespread environmental endocrine disruptor, can cross the blood-brain barrier and exert neurotoxic effects closely associated with depression pathogenesis. However, the precise molecular targets and signaling pathways mediating BPA-induced depression remain poorly understood. This study integrate...
Jin-Lian Zhang, Yuan-Hao Ma, Ming Lu et al.· PLoS ONE· 0 citations
BACKGROUND
Bisphenol A (BPA) is an environmental endocrine disruptor that may contribute to depression. However, its molecular mechanism requires further elucidation.
METHOD
Data from NHANES 2005-2010 were analyzed to evaluate the correlation between BPA and depression. Network pharmacology was used to search for pot...
Han Zhou, Ogula Doubra, Mu-Zi Qian et al.· Environmental Pollution· 0 citations
Phthalates (PAEs), as ubiquitous persistent organic pollutants and typical endocrine disruptors (EDCs), have been shown in epidemiological studies to be associated with the development of osteosarcoma (OS). However, the molecular mechanisms by which PAEs regulate the occurrence and progression of OS remain unclear. Acc...
Hai-Dong Zhou, Hai-Yang Wang, Jun-Xiu Zhou et al.· Ecotoxicology and Environmen...· 0 citations
This study constructs an integrated research framework combining computational prediction and in vitro validation to explore potential molecular mechanisms underlying AED-induced osteoblast dysfunction and osteoporosis.
Chun-Peng Wang, Si-Yang Gao, Min-Jie Wu et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.